| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 77.7% | 76.6% | ▼ -1.1% |
| Healthcare Services | 20.8% | 22.2% | ▲ +1.4% |
| Chemicals & Petrochemicals | 0.9% | 1.1% | ▲ +0.3% |
| IT - Services | 0.5% | 0.0% | ▼ -0.5% |
Comparing Mar 2026 → Apr 2026
| # | Stock | Sector | Last Weight (Mar 2026) |
|---|---|---|---|
| 1 | Sagility Limited ₹14.82 Cr |
IT - Services | 0.54% |
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Max Healthcare Institute Limited ₹71.40 Cr |
Healthcare Services | 1.11% | 2.43% | +1.32% |
| 2 | Fortis Healthcare Limited ₹119.35 Cr |
Healthcare Services | 3.73% | 4.06% | +0.33% |
| 3 | Onesource Specialty Pharma Limited ₹94.64 Cr |
Pharmaceuticals & Biotechnology | 2.91% | 3.22% | +0.31% |
| 4 | Divi's Laboratories Limited ₹242.01 Cr |
Pharmaceuticals & Biotechnology | 7.93% | 8.23% | +0.30% |
| 5 | Eris Lifesciences Limited ₹86.98 Cr |
Pharmaceuticals & Biotechnology | 2.67% | 2.96% | +0.29% |
| 6 | Alkem Laboratories Limited ₹103.08 Cr |
Pharmaceuticals & Biotechnology | 3.25% | 3.51% | +0.26% |
| 7 | Glenmark Pharmaceuticals Limited ₹209.20 Cr |
Pharmaceuticals & Biotechnology | 6.94% | 7.12% | +0.18% |
| 8 | Neogen Chemicals Limited ₹16.86 Cr |
Chemicals & Petrochemicals | 0.42% | 0.57% | +0.15% |
| 9 | Laurus Labs Limited ₹108.75 Cr |
Pharmaceuticals & Biotechnology | 3.56% | 3.70% | +0.14% |
| 10 | Narayana Hrudayalaya Limited ₹38.46 Cr |
Healthcare Services | 1.17% | 1.31% | +0.14% |
| # | Stock | Sector | Mar 2026 | Apr 2026 | Change |
|---|---|---|---|---|---|
| 1 | Rubicon Research Limited ₹2.98 Cr |
Pharmaceuticals & Biotechnology | 0.85% | 0.10% | -0.75% |
| 2 | JB Chemicals & Pharmaceuticals Limited ₹187.86 Cr |
Pharmaceuticals & Biotechnology | 6.88% | 6.39% | -0.49% |
| 3 | Lupin Limited ₹134.32 Cr |
Pharmaceuticals & Biotechnology | 5.06% | 4.57% | -0.49% |
| 4 | Sun Pharmaceutical Industries Limited ₹345.77 Cr |
Pharmaceuticals & Biotechnology | 12.20% | 11.76% | -0.44% |
| 5 | IPCA Laboratories Limited ₹89.01 Cr |
Pharmaceuticals & Biotechnology | 3.32% | 3.03% | -0.29% |
| 6 | Apollo Hospitals Enterprise Limited ₹174.34 Cr |
Healthcare Services | 6.15% | 5.93% | -0.22% |
| 7 | Aster DM Healthcare Limited ₹94.95 Cr |
Healthcare Services | 3.44% | 3.23% | -0.21% |
| 8 | Cipla Limited ₹92.80 Cr |
Pharmaceuticals & Biotechnology | 3.37% | 3.16% | -0.21% |
| 9 | Aurobindo Pharma Limited ₹123.99 Cr |
Pharmaceuticals & Biotechnology | 4.32% | 4.22% | -0.10% |
| 10 | Biocon Limited ₹34.88 Cr |
Pharmaceuticals & Biotechnology | 1.27% | 1.19% | -0.08% |
32 stocks — Apr 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹345.77 Cr |
Pharmaceuticals & Biotechnology |
11.76%
|
|
| 2 |
₹242.01 Cr |
Pharmaceuticals & Biotechnology |
8.23%
|
|
| 3 |
₹209.20 Cr |
Pharmaceuticals & Biotechnology |
7.12%
|
|
| 4 |
₹187.86 Cr |
Pharmaceuticals & Biotechnology |
6.39%
|
|
| 5 |
₹174.34 Cr |
Healthcare Services |
5.93%
|
|
| 6 |
₹134.32 Cr |
Pharmaceuticals & Biotechnology |
4.57%
|
|
| 7 |
₹130.59 Cr |
Pharmaceuticals & Biotechnology |
4.44%
|
|
| 8 |
₹123.99 Cr |
Pharmaceuticals & Biotechnology |
4.22%
|
|
| 9 |
₹119.35 Cr |
Healthcare Services |
4.06%
|
|
| 10 |
₹108.75 Cr |
Pharmaceuticals & Biotechnology |
3.70%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.